Since 2010, Jeff Aronin has been the chairman and chief executive officer of Paragon Pharmaceuticals, an international healthcare development company as well as a biopharmaceutical investment firm. He has also been managing several other Paragon portfolio companies including Harmony Biosciences and Castle Creek Pharmaceuticals.
Before his employment in Paragon pharmaceuticals and between the years 2000 and 2009, Mr. Jeff was the president and the CEO of Ovation Pharmaceuticals Inc. This too is a biopharmaceutical company that he founded in 2000. After the acquisition of his company by Lundbeck, Inc., Aronin found a similar position he had held in Ovation Pharmaceuticals in Paragon. This was however not before he served as the president and CEO of Lundbeck, Inc. until the integration of Ovation Pharmaceuticals.
Having served in the top management level in at least three companies in the pharmaceuticals industry, Jeff Aronin has diverse experience and great skills which include business and strategic development, finance as well as brand marketing. He has worked with three global pharmaceutical industries, which makes his day-to-day management of a global corporation easy and effective. Jeffrey also has great experience in the structuring and execution of strategic corporate connections, such as acquisitions and mergers.
Today, Jeff is among the most influential, successful and innovative leaders in the bioscience industry and he is admired by many people. With over 20 years of experience in global biotech development and healthcare innovations, he can be the best entrepreneur, mentor and innovator the world has at the moment. He has handled several complex science, drug development and rare diseases in the past, which have made him an expert in the field.
He does not work alone though; he has great passion in working together as a team. Throughout his career, he has created great teams of talented individuals, with science and business qualifications to work as researches for drugs and therapies. All his teams have always shown a good track record of performance and have been able to bring new medicines to the market. This has enabled Jeff Aronin to accomplish all the goals he sets in improving the lives of patients, who are sometimes overlooked.